| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 01/08/2015 | WO2015001010A1 Human anti-il-32 antibodies |
| 01/08/2015 | WO2015000886A1 Process |
| 01/08/2015 | WO2015000624A1 Method for producing antibodies using ovine b-cells and uses thereof |
| 01/08/2015 | WO2015000062A1 Egfr antibody conjugates |
| 01/08/2015 | WO2015000059A1 Antibodies to toso |
| 01/08/2015 | US20150011732 Polymer conjugates of interferon beta-1a and uses |
| 01/08/2015 | US20150011729 Nucleotide repeat expansion-associated polypeptides and uses thereof |
| 01/08/2015 | US20150011567 Phosphorylation of histones and uses thereof |
| 01/08/2015 | US20150011431 Humanized antibodies |
| 01/08/2015 | US20150010998 Anti-human ccr7 antibody, hybridoma, nucleic acid, vector, cell, pharmaceutical composition, and antibody-immobilized carrier |
| 01/08/2015 | US20150010982 Methods and Compositions for Generating Bioactive Assemblies of Increased Complexity and Uses |
| 01/08/2015 | US20150010946 Polynucleotides encoding zcytor17 ligand antibodies |
| 01/08/2015 | US20150010926 Methods for predicting pregnancy outcome in a subject by hcg assay |
| 01/08/2015 | US20150010913 Monoclonal antibody for detecting exosomes |
| 01/08/2015 | US20150010599 Pharmaceutical formulation for reducing bladder spasms and method of use thereof |
| 01/08/2015 | US20150010584 Targeted Delivery Of Autoantigens To B Cell Populations |
| 01/08/2015 | US20150010580 Antibodies to clostridium difficile toxins |
| 01/08/2015 | US20150010579 Treatment and Prevention of Gardnerella Vaginalis Infections |
| 01/08/2015 | US20150010578 Delivery of proteins using adeno-associated virus (aav) vectors |
| 01/08/2015 | US20150010577 Translocation and mutant ros kinase in human non-small cell lung carcinoma |
| 01/08/2015 | US20150010574 Anti-igf antibodies |
| 01/08/2015 | US20150010573 Il-17 antibody formulation |
| 01/08/2015 | US20150010572 Ang-2 specific antibodies and uses thereof |
| 01/08/2015 | US20150010571 Rspo binding agents and uses thereof |
| 01/08/2015 | US20150010570 Methods and compositions for using mhc class ii invariant chain polypeptides as a receptor for macrophage migration inhibitory factor |
| 01/08/2015 | US20150010569 Inhibitors Of Complement Activation |
| 01/08/2015 | US20150010568 Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing gdf8 and or activin a |
| 01/08/2015 | US20150010567 Bispecific antibody molecules with antigen-transfected t-cells and their use in medicine |
| 01/08/2015 | US20150010566 Influenza a virus specific antibodies |
| 01/08/2015 | US20150010565 Rspo binding agents and uses thereof |
| 01/08/2015 | US20150010564 Immunoregulation by anti-ilt5 antibodies and ilt5-binding antibody fragments |
| 01/08/2015 | US20150010563 Methods for Treating Corneal and Conjunctival Inflammation and Inflammatory Disorders |
| 01/08/2015 | US20150010562 Pulmonary hypertension |
| 01/08/2015 | US20150010561 Semaphorin 3C (Sema3C) Inhibitor Therapeutics, Methods, and Uses |
| 01/08/2015 | US20150010560 Human pac1 antibodies |
| 01/08/2015 | US20150010559 Anti-tlr4 antibodies and methods of use thereof |
| 01/08/2015 | US20150010558 Compositions and methods for treating coagulation related disorders |
| 01/08/2015 | US20150010557 Propylene Glycol Compositions for Intranasal Administration of Active Agents to the Central Nervous System |
| 01/08/2015 | US20150010556 Serine protease molecules and therapies |
| 01/08/2015 | US20150010555 Compositions and methods for increasing serum half-life |
| 01/08/2015 | US20150010554 Methods for treating interleukin-6 related diseases |
| 01/08/2015 | US20150010553 Methods of treating inflammatory diseases using antibodies that bind both il-17a and il-17f |
| 01/08/2015 | US20150010552 Compositions and methods for treating inflammation and fibrosis |
| 01/08/2015 | US20150010551 Compositions and Methods of Treating Tumors |
| 01/08/2015 | US20150010550 OPTIMIZED Fc VARIANTS |
| 01/08/2015 | US20150010548 Stabilized Aqueous Antibody Compositions |
| 01/08/2015 | US20150010547 Treatment of allergic diseases with recombinant antibodies |
| 01/08/2015 | US20150010546 Sequences directed against hepatocyte growth factor (hfg) and polypeptides comprising the same for the treatment of cancers and/or tumors |
| 01/08/2015 | US20150010544 Compounds and methods for treating inflammatory diseases |
| 01/08/2015 | US20150010543 OPTIMIZED Fc VARIANTS |
| 01/08/2015 | US20150010542 Antibodies to toso |
| 01/08/2015 | US20150010540 Combination therapy of an afucosylated cd20 antibody with a cd22 antibody-drug conjugate |
| 01/08/2015 | US20150010539 Anti-cd25 antibodies and their uses |
| 01/08/2015 | US20150010538 Anti-cd25 antibodies and their uses |
| 01/08/2015 | US20150010536 Humanized PAI-1 Antibodies and Uses Thereof |
| 01/08/2015 | US20150010535 Methods of Identifying a Compound that Increases or Decreases the Interaction of Hn-33 with Synaptotagmin II |
| 01/08/2015 | US20150010534 Methods and Compositions for Treatment and Prevention of Major Depressive Disorder |
| 01/08/2015 | US20150010495 Method for the production of an immunostimulating mucin (muc1) |
| 01/08/2015 | US20150010477 Method for the Treatment of Multiple Sclerosis |
| 01/07/2015 | EP2821417A2 Recombinant antibodies having dual specificity for gangliosides and use thereof |
| 01/07/2015 | EP2821416A1 Novel anti-human il-23 receptor antibody |
| 01/07/2015 | EP2821415A1 Anti-lipoarabinomannan antibody and immunoassay for mycobacteriosis using said antibody |
| 01/07/2015 | EP2820947A1 Transgenic non-human mammal for producing chimeric human immunoglobulin E antibodies |
| 01/07/2015 | EP2820153A1 Method of identifying vdj recombination products |
| 01/07/2015 | EP2820048A1 Antibodies to matrix metalloproteinase 9 |
| 01/07/2015 | EP2820047A1 Long life polypeptide binding molecules |
| 01/07/2015 | EP2820046A1 Cx3cr1-binding polypeptides |
| 01/07/2015 | EP2820045A1 Methods for the treatment of b cell-mediated inflammatory diseases |
| 01/07/2015 | EP2820044A1 Human antibodies to clostridium difficile toxins |
| 01/07/2015 | EP2820043A1 Pseudomonas aeruginosa pcrv binding single variable domain antibodies |
| 01/07/2015 | EP2820042A2 Igg stimulated remyelination of peripheral nerves |
| 01/07/2015 | EP2820041A1 Iaspp phosphorylation and metastatic potential |
| 01/07/2015 | EP2819702A1 Novel prodrug containing molecule compostions and their uses |
| 01/07/2015 | EP2819701A1 Immunotherapeutic molecules and uses |
| 01/07/2015 | CN104272111A 检测结核的方法 TB detection method |
| 01/07/2015 | CN104271603A 抗-ErbB2抗体变异体 Anti -ErbB2 antibody variants |
| 01/07/2015 | CN104271602A 双特异性抗体 Bispecific antibody |
| 01/07/2015 | CN104271601A 使用pd-1轴结合拮抗剂和vegf拮抗剂治疗癌症的方法 Use pd-1 axis antagonist binding antagonists and methods of treating cancer vegf |
| 01/07/2015 | CN104271600A 稳定化的蛋白溶液 Stabilized protein solution |
| 01/07/2015 | CN104271599A 使用抗m-csf抗体治疗炎性疾病的方法 Antibody using an anti-m-csf method of treating an inflammatory disease |
| 01/07/2015 | CN104271598A 针对IgE的免疫球蛋白单可变结构域 Immunoglobulin single variable domains of IgE against |
| 01/07/2015 | CN104271597A Hiv-1的中和抗体及其用途 Hiv-1 neutralizing antibodies and uses thereof |
| 01/07/2015 | CN104271158A 多种抗人csf-1r抗体的联合疗法及其用途 More anti-human csf-1r antibody combination therapy and its use |
| 01/07/2015 | CN104271148A 红细胞结合性治疗剂 Erythrocyte binding of the therapeutic agent |
| 01/07/2015 | CN104271122A 抗vla1(cd49a)抗体药物组合物 Anti vla1 (cd49a) antibody pharmaceutical compositions |
| 01/07/2015 | CN104263746A 猪Six1蛋白的体外表达及其多克隆抗体的制备方法 Six1 protein expression in vitro and pig polyclonal antibody preparation |
| 01/07/2015 | CN104263740A Axmi-il5、axmi-113、axmi-005、axmi-163 和axmi-184∶vip3a 杀虫蛋白及其使用方法 Axmi-il5, axmi-113, axmi-005, axmi-163 and axmi-184:vip3a insecticidal proteins and methods of use |
| 01/07/2015 | CN104263701A 一株氯霉素类通用性单克隆抗体杂交瘤细胞株及其应用 A chloramphenicol generic monoclonal antibody hybridoma cell line and its applications |
| 01/07/2015 | CN104262486A 杂交瘤细胞株fq-2g3,其产生的抗甲基毒死蜱单克隆抗体及免疫层析试纸条 Hybridoma cell line fq-2g3, which produces monoclonal antibodies and anti-methyl chlorpyrifos Immunochromatographic strip |
| 01/07/2015 | CN104262485A 罗非鱼sIgM截短重链恒定区蛋白多克隆抗体及其制备方法 Tilapia sIgM truncated heavy chain constant region polyclonal antibodies and methods |
| 01/07/2015 | CN104262484A 一种抗非洲猪瘟病毒的特异性IgY抗体及制备方法和用途 An anti-African swine fever virus-specific IgY antibody and preparation and use |
| 01/07/2015 | CN104262483A 用于生成抗体混合物的方法 Method for the production of antibody mixture |
| 01/07/2015 | CN103509757B 杂交瘤细胞株15号及其产生的抗拟除虫菊酯的群选性单克隆抗体 Hybridoma cell lines on the 15th and the resulting anti-pyrethroid group selected monoclonal antibodies |
| 01/07/2015 | CN103421747B 分泌牛il-4单克隆抗体的杂交瘤细胞株、其单克隆抗体及其应用 Cattle il-4 secretion of monoclonal antibody hybridoma cell lines, monoclonal antibodies and their application |
| 01/07/2015 | CN103305473B 抗蓝舌病病毒血清1型vp2蛋白的单克隆抗体btv1-4b6及其识别的b细胞表位多肽与应用 B-cell epitope peptide and application of anti-bluetongue virus type 1 vp2 serum proteins and monoclonal antibodies recognized btv1-4b6 |
| 01/07/2015 | CN103288960B 吉他霉素残留检测用基因工程抗体及制备方法和应用 Kitasamycin residues genetically engineered antibody preparation method and application use |
| 01/07/2015 | CN103146652B 抗喹乙醇单克隆抗体及其杂交瘤细胞株、其制备方法及用于检测饲料中喹乙醇的试剂盒 Monoclonal antibodies and anti olaquindox hybridoma cell lines, their preparation and for the detection of feed olaquindox kit |
| 01/07/2015 | CN102988959B Nkg2d的调节 Nkg2d regulation |
| 01/07/2015 | CN102659883B 食品辐照标志物DiHT类通用半抗原、人工抗原及其制备方法与应用 Food irradiation markers DiHT class generic hapten, artificial antigen and its preparation method and application |
| 01/07/2015 | CN102639564B 抗-cmet抗体及其用于癌症的检测和诊断的用途 -cmet Antibodies and their use for anti-cancer detection and diagnosis |